These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 39076905)

  • 1. Construction of Prediction Model for Atrial Fibrillation with Valvular Heart Disease Based on Machine Learning.
    Li Q; Lei S; Luo X; He J; Fang Y; Yang H; Liu Y; Deng CY; Wu S; Xue YM; Rao F
    Rev Cardiovasc Med; 2022 Jul; 23(7):247. PubMed ID: 39076905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of key immune-related genes and immune infiltration in atrial fibrillation with valvular heart disease based on bioinformatics analysis.
    Li S; Jiang Z; Chao X; Jiang C; Zhong G
    J Thorac Dis; 2021 Mar; 13(3):1785-1798. PubMed ID: 33841968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive analysis of autophagy-related genes and patterns of immune cell infiltration in valvular atrial fibrillation.
    Liu A; Jia K; Liang H; Jin Q
    BMC Cardiovasc Disord; 2021 Mar; 21(1):132. PubMed ID: 33706714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profile associated with chronic atrial fibrillation and underlying valvular heart disease in man.
    Lamirault G; Gaborit N; Le Meur N; Chevalier C; Lande G; Demolombe S; Escande D; Nattel S; Léger JJ; Steenman M
    J Mol Cell Cardiol; 2006 Jan; 40(1):173-84. PubMed ID: 16242148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human atrial ion channel and transporter subunit gene-expression remodeling associated with valvular heart disease and atrial fibrillation.
    Gaborit N; Steenman M; Lamirault G; Le Meur N; Le Bouter S; Lande G; Léger J; Charpentier F; Christ T; Dobrev D; Escande D; Nattel S; Demolombe S
    Circulation; 2005 Jul; 112(4):471-81. PubMed ID: 16027256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and validation of potential biomarkers for atrial fibrillation based on integrated bioinformatics analysis.
    Tong F; Sun Z
    Front Cell Dev Biol; 2023; 11():1190273. PubMed ID: 38274270
    [No Abstract]   [Full Text] [Related]  

  • 7. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
    Lip GYH; Collet JP; Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B;
    Europace; 2017 Nov; 19(11):1757-1758. PubMed ID: 29096024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of common mechanisms and biomarkers of atrial fibrillation and heart failure based on machine learning.
    Zhang Z; Ding J; Mi X; Lin Y; Li X; Lian J; Liu J; Qu L; Zhao B; Li X
    ESC Heart Fail; 2024 Aug; 11(4):2323-2333. PubMed ID: 38656659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of potential roles of combinatorial microRNA regulation in occurrence of valvular heart disease with atrial fibrillation based on computational evidences.
    Wang G; Rao N; Liu D; Jiang H; Liu K; Yang F; Chen Y; Huang K
    PLoS One; 2019; 14(9):e0221900. PubMed ID: 31479479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrative Identification of Hub Genes Associated With Immune Cells in Atrial Fibrillation Using Weighted Gene Correlation Network Analysis.
    Yan T; Zhu S; Zhu M; Wang C; Guo C
    Front Cardiovasc Med; 2020; 7():631775. PubMed ID: 33553270
    [No Abstract]   [Full Text] [Related]  

  • 11. Integrative transcriptomic, proteomic, and machine learning approach to identifying feature genes of atrial fibrillation using atrial samples from patients with valvular heart disease.
    Liu Y; Bai F; Tang Z; Liu N; Liu Q
    BMC Cardiovasc Disord; 2021 Jan; 21(1):52. PubMed ID: 33509101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: evaluating 'valvular heart disease' in a nationwide cohort study.
    Lip GYH; Jensen M; Melgaard L; Skjøth F; Nielsen PB; Larsen TB
    Europace; 2019 Jan; 21(1):33-40. PubMed ID: 29986001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence, Characteristics, and Outcomes of Valvular Heart Disease in Patients With Atrial Fibrillation: Insights From the ORBIT-AF (Outcomes Registry for Better Informed Treatment for Atrial Fibrillation).
    Thomas KL; Jackson LR; Shrader P; Ansell J; Fonarow GC; Gersh B; Kowey PR; Mahaffey KW; Singer DE; Thomas L; Piccini JP; Peterson ED
    J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29273635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune-associated pivotal biomarkers identification and competing endogenous RNA network construction in post-operative atrial fibrillation by comprehensive bioinformatics and machine learning strategies.
    Zhou Y; Wu Q; Ni G; Hong Y; Xiao S; Liu C; Yu Z
    Front Immunol; 2022; 13():974935. PubMed ID: 36341343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the pathogenesis and immune infiltration in dilated cardiomyopathy complicated with atrial fibrillation by bioinformatics analysis.
    Gan T; Hu J; Aledan AKO; Liu W; Li C; Lu S; Wang Y; Xu Q; Wang Y; Wang Z
    Front Immunol; 2023; 14():1049351. PubMed ID: 36733486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L1 cell adhesion molecule may be a protective molecule for atrial fibrillation in patients with valvular heart disease.
    Wang D; Hu B; Xu G; Wei R; Liu Z; Wu H; Xu L; Huang S; Hou J
    Heliyon; 2023 Jun; 9(6):e16831. PubMed ID: 37303506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Valvular Heart Disease on Mortality, Thromboembolic and Cardiac Events in Japanese Patients With Atrial Fibrillation　- The Fushimi AF Registry.
    Doi K; Ogawa H; Ishigami K; Ikeda S; Aono Y; Hamatani Y; Fujino A; An Y; Ishii M; Iguchi M; Masunaga N; Esato M; Tsuji H; Wada H; Hasegawa K; Abe M; Akao M;
    Circ J; 2020 Apr; 84(5):714-722. PubMed ID: 32213725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease: Executive Summary of a Joint Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, Endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
    Lip GYH; Collet JP; de Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B
    Thromb Haemost; 2017 Dec; 117(12):2215-2236. PubMed ID: 29212110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Hub mRNAs and lncRNAs in Atrial Fibrillation Using Weighted Co-expression Network Analysis With RNA-Seq Data.
    Yang P; Cao Y; Jian H; Chen H
    Front Cell Dev Biol; 2021; 9():722671. PubMed ID: 34671599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the shared biomarkers between cardioembolic stroke and atrial fibrillation by WGCNA and machine learning.
    Zhang J; Zhang B; Li T; Li Y; Zhu Q; Wang X; Lu T
    Front Cardiovasc Med; 2024; 11():1375768. PubMed ID: 39267804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.